Relative to CSII, an implantable, programmable pump supplying insulin intravenously or intraperitoneally provided excellent glycaemic control with few hypoglycaemic episodes. It is sited subcutaneously in the lower left abdomen and only required filling on average once every two months.
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page